The latest issue of European Biotechnology covers the ins and outs of gene therapy pricing, sustainable finance and antimicrobial resistance.
BIOCOM is part of the new EU project COMBINE, which aims to develop new solutions for the development of antimicrobial agents.
For the 32nd time, the standard work of the biotechnology industry in Germany, Austria and Switzerland has been published. Once again, this year’s BioTechnology Yearbook provides a comprehensive overview of the various aspects of this sector of the economy
Novel biomarkers are the focus of the latest issue of European Biotechnology. Other stories cover malaria vaccinations, biomanufacturing and the bioeconomy.
The BMEL has commissioned BIOCOM to organise and implement the Global Forum for Food and Agriculture GFFA.
Radiopharmaceuticals have made it to the title of the second issue of |transkript this year, next to topics such as haemophilia, synthetical bacterial genomes and biomanufacturing.
Although the Swiss biotech sector continues to grow and the annual Swiss Biotech Day is as sought-after as never before, panelists and attendees remain cautious with their predictions.
The 9th edition of the European Biotechnology Science & Industry Guide once more offers an interesting cross-section of the European biotech scene.
BIOCOM AGMore than 330 international experts came to Berlin for the twelfth Berlin Conference on Life Sciences to discuss the most urgent challenges in the fight against antibiotic resistance.
BIOCOMFighting metastases: The cover story in the newly published European Biotechnology presents the latest approaches in the fight against cancer.